MEDIFAST INC 8-K

What Happened Medifast Inc. (MED) announced that Jason L. Groves, the Company's Chief Legal Officer & Corporate Secretary, tendered his resignation effective May 29, 2026. On May 31, 2026, the Company and Mr. Groves entered into a Separation Agreement under which he will receive a one-time lump-sum cash severance payment equal to one month of his annual base salary (less taxes and withholdings). The payment is conditioned on Mr. Groves’ non-revocation of the Separation Agreement and his compliance with its terms. The filing states the departure was not due to any disagreement with the Company’s operations, policies or practices, and Medifast has begun a search for a permanent replacement. The 8-K was filed June 1, 2026.

Key Details

• Resignation effective date: May 29, 2026 (Jason L. Groves).
• Separation Agreement executed: May 31, 2026.
• Severance: one-time lump-sum cash payment equal to one month of Mr. Groves’ annual base salary, subject to taxes, non-revocation and compliance.
• Filing notes no disagreement with the Company; Company has commenced search for replacement.
• Separation Agreement is filed as Exhibit 10.1 to the 8-K.

Why It Matters For investors, this is a leadership change in the company’s legal and corporate secretary role. The disclosed severance is limited (one month’s salary) and tied to conditions, suggesting minimal direct financial impact disclosed in the filing. The company’s statement that the departure was not due to any disagreement may reduce immediate governance concerns, but investors should watch for updates on a permanent replacement and any related disclosures.